COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures

Rocklöv, Joacim; Sjödin, Henrik; Wilder‐Smith, Annelies

doi:10.1093/jtm/taaa030

Cited by 463 publications

(486 citation statements)

References 17 publications

Supporting

Mentioning

433

Contrasting

Unclassified

Order By: Relevance

“…The high attack rates on the cruise ship Diamond Princess in Japan, with more than 700 on board infected out of approximately 3700 cruise ship passengers and crew members by Feb 28, 2020, despite public health measures, suggest a very high transmissibility. 40 A fourth explanation is that the clinical spectrum is different. China's initial case definition was focused on pneumonia, and initial case fatality rates (CFR) were reported at about 10% on the basis of this narrow case definition.…”

Section: Prevention Of Global Spreadmentioning

confidence: 99%

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Wilder‐Smith

Chiew

Lee

2020

The Lancet Infectious Diseases

839

773

View full text Add to dashboard Cite

The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine. By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82 000 confirmed cases of COVID-19 have been reported with more than 2800 deaths. Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19. COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. Exportations to other countries need not result in rapid large-scale outbreaks, if countries have the political will to rapidly implement countermeasures.

show abstract

Section: Prevention Of Global Spreadmentioning

confidence: 99%

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Wilder‐Smith

Chiew

Lee

2020

The Lancet Infectious Diseases

839

773

View full text Add to dashboard Cite

show abstract

“…However, the implementation of isolation and quarantine procedures helped prevent the spread of COVID-19 in more than 2,000 passengers and lowered the R 0 to 1.78. 6 Although the experience of this cruise ship provided a good model for understanding the behavior of COVID-19 spread, the spread of disease could have been prevented if all passengers and crew were evacuated early.…”

Section: International Conveyance (Diamond Princess)mentioning

confidence: 99%

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

Lai

Wang

et al. 2020

International Journal of Antimicrobial Agents

370

278

View full text Add to dashboard Cite

“…At the time of writing, a significant number of cases had occurred in the Far East. It is incontestably contagious, as a quasiexperimental study on the Diamond Princess cruise ship showed that confinement of infected patients with uninfected patients resulted in rapid infection of the uninfected patients, leading to 700 additional cases on board [21]. However, coronaviruses in common circulation remain predominant because of their global distribution and their non-negligible mortality [14,22].…”

Section: Introductionmentioning

confidence: 99%

SARS-CoV-2: fear versus data

Roussel

Giraud-Gatineau

Jimeno

et al. 2020

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

Highlights Comparison of incidence and mortality rates of four common coronaviruses circulating in France with those of SARS-COV-2 in OECD countries. As of 2 March 2020, 90 307 patients had tested positive for SARS-CoV-2 worldwide, with 3086 deaths (mortality rate 3.4%). As of 2 March 2020, among OECD countries, 7476 patients had tested positive for SARS-CoV-2, with 96 deaths (mortality rate 1.3%)  As of 2 March 2020, in France, 191 people had tested positive for SARS-CoV-2, with three deaths (mortality rate 1.6%). In OECD countries. the mortality rate for SARS-CoV-2 (1.3%) is not significantly different from that for common coronaviruses identified at the study hospital in France (0.8%; P=0.11). The problem of SARS-CoV-2 is probably overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing. ABSTRACT SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-COV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.

show abstract

COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures

Abstract: Background: Cruise ships carry a large number of people in confined spaces with relative

Cited by 463 publications

References 17 publications

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

SARS-CoV-2: fear versus data

Contact Info

Product

Resources

About